# FDA Inspection 1216323 - Reproductive Medicine Institute - August 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/3f4f85d9-e5e9-4637-9832-74667f54431d
Source feed: FDA_Inspections

> FDA Inspection 1216323 for Reproductive Medicine Institute on August 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216323
- Company Name: Reproductive Medicine Institute
- Inspection Date: 2023-08-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1216323 - 2023-08-17](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/f8d088aa-865c-464b-9648-497eaed6c1bb)
- [FDA Inspection 1216323 - 2023-08-17](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/9b84cef1-117a-40a3-ba53-9c92daad36b2)
- [FDA Inspection 1062789 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/29ed43df-b2ee-4f65-a7b8-240d6aa2b714)
- [FDA Inspection 1062789 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/d83594bf-b9d2-4028-81e6-9bd4035acefd)

Company: https://www.keypedia.com/companies/reproductive-medicine-institute/515f31f2-b074-46c5-a31a-8bffa09eaa04

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d